✦ LIBER ✦

Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: A Phase II Study of the Gynecologic Oncology Group

✍ Scribed by Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; Mark Morgan; Parviz Hanjani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II evaluation of tirapazamine pl

✍ Allan Covens; John Blessing; David Bender; Robert Mannel; Mark Morgan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A phase II evaluation of bortezomib in t

✍ Carol Aghajanian; John A. Blessing; Kathleen M. Darcy; Gary Reid; Koen DeGeest; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 589 KB

Phase II Trial of Bevacizumab in Persist

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

A phase I trial of gemcitabine and topot

✍ M. Dwight Chen; Gini F. Fleming; Suann Mitchell; Ira Horowitz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A phase II trial of paclitaxel poliglume

✍ Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Sec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Evaluation of Cisplatin and Cyclosporin

✍ Alberto Manetta; John A. Blessing; Jean A. Hurteau 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 29 KB